2026
Mirăuță B, Riza A-L, Streata I, Pirvu A, Dorobantu S, Dragos A, Surleac M, Netea MG, “Resistome and microbiome-immune interactions in an Eastern European population with high antibiotic use”, Microbiol Spectr.; 14(9):e0052826, 2026. [PMID: 42578673] -- P1, P4 -- Q1 -- (IF = 4.1, AIS (2025) = 0.994)
Nedea MI, Velicu SS, Marinas IC, Buleandra M, Letitia Arsene A, Velescu BS, Chifiriuc MC, Gheorghe-Barbu I, “In vitro and in vivo antifungal effects of fluconazole in combination with Cinnamomum verum essential oil against Candida spp.”, Front Pharmacol.; 17:1864146, 2026. [PMID: 42460008] -- CO -- Q1 -- (IF = 5.4, AIS (2025) = 1.039)
Jula DT, Badea M, Maxim C, Marinas IC, Gaboreanu MD, Rostas AM, Suciu M, Ruta L, Farcasanu I, Tirsoaga A, Iorgulescu EE, Chifiriuc MC, Iordanescu V, Olar R, “Redox-active copper(II) complexes with mixed heterocyclic N-donor ligands as dual antimicrobial and anti-tumor agents”, Eur J Med Chem.; 316:119003, 2026. [PMID: 42208367] -- CO -- Q1 -- (IF = 6.7, AIS (2025) = 0.991)
Marinaş IC, Mük GR, Voicu SN, Stoian M, Kuncser A, Neatu F, Mirea AG, Ciobotaru CI, Florea M, Oprea O, Avram S, Anghel EM, Culita DC, Tudose M, Chifiriuc MC, “Moxifloxacin-conjugated graphene oxide: Antimicrobial, anti-adhesive and cell-selective properties supporting its potential for future biomedical coatings”, Biomater Adv.; 188:215009, 2026. [PMID: 42287939] -- CO -- Q1 -- (IF = 6.7, AIS (2025) = 0.943)
Marinas IC, Nicolescu A, Al-Matarneh CM, Vrabie R, Shova S, Silion M, Gaboreanu MD, Stan M, Chifiriuc MC, Pinteala M, “Heterocyclic chemistry meets wound care: novel p-methyl-m-trifluoromethyl-phenyl-substituted pyrrol-2-one derivatives with antimicrobial and antibiofilm activity”, RSC Adv.; 16(40):46074-46093, 2026. [PMID: 42568943] -- CO, P6 -- Q1 -- (IF = 6.1, AIS (2025) = 0.670)
Ungureanu D, Marc G, Duma MN, Vodnar DC, Martău GA, Vlase L, Pîrnău A, Tiperciuc B, Moldovan C, Ionuț I, Stana A, Oniga I, Oniga O, “Thiazolyl-Methylthio-1,3,4-Thiadiazole Hybrids as Halicin Analogues with Antimicrobial and Antibiofilm Activities: Chemical Development, Biological Assessment, and 2D-QSAR Study”, Antibiotics (Basel); 15(5):448, 2026. [PMID: 42192670] -- P3 -- Q1 -- (IF = 5.5, AIS (2025) = 0.963)
Lupu A, Grădinaru LM, Bercea M, Avădanei M, Grădinaru VR, Roșca I, Rusu D, “Smart supramolecular hydrogels as a potential platform for wound dressings: Harnessing thiamine to boost neomycin efficacy”, React. Funct. Polym.; 221:106648, 2026. -- P6 -- Q1 -- (IF = 5.4, AIS (2025) = 0.609)
Plugariu IA, Gradinaru LM, Popescu I, Bercea M, “Highlighting the anti-inflammatory activity of topical gels loaded with meloxicam: the role of different excipients and absorption promoters”, Polymers (Basel); 18(17):2065, 2026. [PMID: 42737074] -- P6 -- Q1 -- (IF = 5.8, AIS (2025) = 0.752)
Limban C, Marinaş IC, Chifiriuc MC, Căproiu MT, Dumitraşcu F, Kapronczai FE, Zarafu I, Nuţă DC, Ioniţă P, Avram S, Mareş C, Păun AM, Cristea BM, Bădiceanu CD, Vlad IM, Coandă M, Popescu DL, Bleotu C, “Novel Carbazole–Acylthiourea Derivatives: Synthesis, Antimicrobial, Antioxidant, Hemocompatibility, Cytotoxicity, and ADME-Tox Profiling”, ChemistryOpen; 15(11):e70258, 2026. [PMID: 42862714] -- P2, CO -- Q2 -- (IF = 3.0, AIS(2025) = 0.482)
Paun VI, Itcus C, Lavin P, Chifiriuc MC, Purcarea C, “First genome sequence and functional profiling of Psychrobacter SC65A.3 preserved in 5,000-year-old cave ice: insights into ancient resistome, antimicrobial potential, and enzymatic activities”, Front Microbiol.; 16:1713017, 2026. [PMID: 41783148] -- CO -- Q1 -- (IF = 5.8, AIS (2026) = 1.082)
Hostiuc M, Afrasanie VA, Andronic O, Forray AI, Hostiuc S, Ionescu AI, Ionescu RT, Karakasis P, Musina AM, Negoi R, Oancea B, Patoulias D, Rusu MC, Scafa A, Negoi I, “Nonfatal Burden of Disease and Risk-Attributable Burden in Romania, 1990 to 2023: A Secondary Analysis of Global Burden of Disease 2023 Estimates”, Healthcare (Basel);14(18):3035, 2026. [PMID: 42793573] -- CO -- Q2 -- (IF = 3.4)
GBD 2023 Cervical Cancer Collaborators, “Global, regional and national burden of cervical cancer in 1990-2023 with forecasts to 2050: a Global Burden of Disease study”, Nat Med.; 2026. [PMID: 42972107] -- CO -- Q1 -- (IF = 52.3, AIS(2025) = 21.969)
Hostiuc S, Volovat S, Steiropoulos P, Scafa A, Rusu MC, Oancea B, Negoi R, Negoi I, Musina AM, Mulita F, Ionescu RT, Forray AI, Carstea AE, Andronic O, Afrasanie VA, Hostiuc M, “Causes of Death and Years of Life Lost in Romania, 1980–2023: An Analysis of GBD 2023 Mortality Estimates”, Epidemiologia; 7(6):155, 2026. [PMID:] -- CO -- Q2 -- (IF = 3.2)
Marinaș I. C., Gaboreanu M. D., Voicu S. N., Stoian M., Kuncser A., Toderascu L. I., Socol G., Oprea O., Culita D.C., Tudose M., Chifiriuc M.C., “Surface modification of gold nanoparticles with a coumarin derivative for oxidative stress control, antimicrobial efficacy, and tissue regeneration”, Applied Surface Science; 731, 166471, 2026. -- CO -- Q1 -- (IF =6.6, AIS (2025)= 0.820).
*Notes: Blue font highlights mentor's name. Q classification is done based on SCImago. Article Influence Score (AIS) and Impact Factor (IF) are taken from WOS Clarivate. AIS and IF will be updated one year after the publishing year.